<DOC>
	<DOCNO>NCT02315495</DOCNO>
	<brief_summary>The propose study design evaluate ( ) effect saxagliptin , without acarbose , gastric emptying , postprandial glycaemia , plasma intact GLP-1 , insulin , C-peptide glucagon high carbohydrate meal , ( ii ) whether magnitude effect saxagliptin and/or acarbose related rate gastric emptying , patient type 2 diabetes .</brief_summary>
	<brief_title>Combining Saxagliptin Acarbose Improve Postprandial Glycaemia Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Type 2 diabetes ( World Health Organisation ( WHO ) criterion ) , manage diet alone ( i.e . oral hypoglycaemic drug insulin ) Body mass index ( BMI ) 20 40 kg/m2 Age 18 70 year Males postmenopausal female ( control effect menstrual cycle gut hormone secretion ) Glycated haemoglobin A1c ( HbA1c ) ≥ 6.0 % ≤ 7.9 % Haemoglobin low limit normal range ( i.e . &gt; 135g/L men 115g/L woman ) , ferritin low limit normal ( i.e . &gt; 10mcg/L ) Use medication may influence gastrointestinal motor function , body weight appetite Evidence drug abuse , consumption 20 g alcohol 10 cigarette daily basis History gastrointestinal disease , include significant upper low gastrointestinal symptom , pancreatitis , previous gastrointestinal surgery ( uncomplicated appendicectomy cholecystectomy ) Other significant illness , include epilepsy , cardiovascular respiratory disease Autonomic nerve damage ( assess standardise cardiovascular reflex test [ 36 ] ) Impaired renal liver function ( assess calculate creatinine clearance &lt; 90 mL/min abnormal liver function test ( &gt; 2 time upper limit normal range ) ) Allergy vildagliptin 'gliptin ' Donation blood within previous 3 month Participation research study within previous 3 month Females premenopausal Inability give inform consent Vegetarians</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>